Does VOTRIENT Cause Malignant neoplasm progression? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Malignant neoplasm progression have been filed in association with VOTRIENT. This represents 3.0% of all adverse event reports for VOTRIENT.
18
Reports of Malignant neoplasm progression with VOTRIENT
3.0%
of all VOTRIENT reports
7
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From VOTRIENT?
Of the 18 reports, 7 (38.9%) resulted in death, 4 (22.2%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VOTRIENT. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does VOTRIENT Cause?
Death (167)
Hypertension (65)
Nausea (59)
Diarrhoea (54)
Fatigue (52)
Vomiting (44)
Decreased appetite (40)
Investigation (40)
Disease progression (38)
Asthenia (37)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which VOTRIENT Alternatives Have Lower Malignant neoplasm progression Risk?
VOTRIENT vs VOXELOTOR
VOTRIENT vs VUTRISIRAN
VOTRIENT vs VX-950
VOTRIENT vs VYVANSE
VOTRIENT vs WARFARIN